Takeshi Enomoto Selected Research

Takeshi Enomoto Research Topics

10	Schizophrenia (Dementia Praecox) 12/2019 - 12/2005
6	Cognitive Dysfunction 01/2018 - 07/2005
3	Psychotic Disorders (Schizoaffective Disorder) 08/2013 - 07/2007
2	Neurobehavioral Manifestations 12/2019 - 06/2009
1	Dyskinesias (Dyskinesia) 01/2021
1	Parkinson Disease (Parkinson's Disease) 01/2021
1	Central Nervous System Diseases (CNS Diseases) 01/2018
1	Brain Injuries (Brain Injury) 07/2005
1	Traumatic Brain Injuries (Traumatic Brain Injury) 07/2005
1	Brain Ischemia (Cerebral Ischemia) 08/2004
1	Brain Contusion 08/2004

3	Antipsychotic Agents (Antipsychotics)IBA 01/2018 - 12/2005
3	N-Methylaspartate (NMDA)IBA 05/2016 - 07/2007
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 05/2016 - 12/2005
3	Phencyclidine (Angel Dust)IBA 06/2009 - 12/2005
2	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2021 - 12/2019
2	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2018 - 02/2013
2	Ketamine FDA LinkGeneric 05/2016 - 06/2009
2	blonanserinIBA 05/2016 - 01/2015
2	Dopamine D3 ReceptorsIBA 05/2016 - 03/2015
2	MagnesiumIBA 07/2005 - 08/2004
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2021
1	Levodopa (L Dopa)FDA LinkGeneric 01/2021
1	Cholinergic Agents (Cholinergics)IBA 01/2018
1	LigandsIBA 01/2018
1	Pharmaceutical PreparationsIBA 01/2018
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2018
1	Haloperidol (Haldol)FDA LinkGeneric 01/2015
1	tandospironeIBA 01/2015
1	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2015
1	5-HT1A Serotonin ReceptorIBA 01/2015
1	Methamphetamine (Desoxyn)FDA LinkGeneric 02/2013
1	Apomorphine FDA Link 02/2013
1	GABA-A Receptors (GABA(A) Receptor)IBA 03/2011
1	BicucullineIBA 03/2011
1	gamma-Aminobutyric Acid (GABA)IBA 03/2011
1	Dopamine (Intropin)FDA LinkGeneric 03/2011
1	Lurasidone Hydrochloride FDA Link 01/2008
1	SolutionsIBA 07/2005
1	salicylhydroxamic acid (SHAM)IBA 07/2005
1	Dihydrotachysterol (AT 10)IBA 07/2005
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 07/2005
1	Neuroprotective AgentsIBA 08/2004

1	Therapeutics 01/2015
1	Oral Administration 08/2013